IRVINE, Calif., Feb. 02, 2022 — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced that it will be hosting a fireside chat and participating in one-on-one investor meetings at SVB Leerink’s Virtual Global Healthcare Conference taking… Continue reading Reneo Pharmaceuticals to Participate in SVB Leerink Virtual Global Healthcare Conference
